Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9884158rdf:typepubmed:Citationlld:pubmed
pubmed-article:9884158lifeskim:mentionsumls-concept:C0001973lld:lifeskim
pubmed-article:9884158lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9884158lifeskim:mentionsumls-concept:C0066908lld:lifeskim
pubmed-article:9884158lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:9884158pubmed:issue9lld:pubmed
pubmed-article:9884158pubmed:dateCreated1999-3-29lld:pubmed
pubmed-article:9884158pubmed:abstractTextMu-Opioid receptor-mediated neurotransmission is involved in the reward, tolerance, and withdrawal effects of alcohol. The present association study tested the hypothesis that the common Asn40Asp substitution polymorphism in the N-terminal domain of the human mu-opioid receptor (OPRM) confers vulnerability to subtypes of alcohol dependence. The genotypes of the Asn40Asp substitution polymorphism were assessed in 327 German alcohol-dependent subjects (according to ICD-10) and in 340 control subjects of German descent, using an assay based on allele-specific polymerase chain reaction. To select alcoholics with a presumed high genetic load, three subgroups were delineated, marked by (1) a family history of parental alcoholism (n = 114); (2) the inability to abstain from alcohol before the age of 26 years (n = 73); and (3) a history of alcohol withdrawal seizure or delirium (n = 107). The frequency of the Asp40 allele did not differ significantly between the controls [f(Asp40) = 0.078] and either the entire group of alcoholics [f(Asp40) = 0.107; p = 0.066], or the alcoholics with parental alcoholism [f(Asp40) = 0.114; p = 0.094], or the early-onset alcoholics [f(Asp40) = 0.096; p = 0.471,[ or the alcoholics with severe withdrawal symptoms [f(Asp40) = 0.098; p = 0.350]. Our results do not provide evidence that the common Asn40Asp substitution polymorphism of the OPRM gene contributes a major effect to the pathogenesis of alcohol dependence.lld:pubmed
pubmed-article:9884158pubmed:languageenglld:pubmed
pubmed-article:9884158pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9884158pubmed:citationSubsetIMlld:pubmed
pubmed-article:9884158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9884158pubmed:statusMEDLINElld:pubmed
pubmed-article:9884158pubmed:monthDeclld:pubmed
pubmed-article:9884158pubmed:issn0145-6008lld:pubmed
pubmed-article:9884158pubmed:authorpubmed-author:SchmidtL GLGlld:pubmed
pubmed-article:9884158pubmed:authorpubmed-author:Rommelspacher...lld:pubmed
pubmed-article:9884158pubmed:authorpubmed-author:HoeheM RMRlld:pubmed
pubmed-article:9884158pubmed:authorpubmed-author:SanderTTlld:pubmed
pubmed-article:9884158pubmed:authorpubmed-author:SmolkaMMlld:pubmed
pubmed-article:9884158pubmed:authorpubmed-author:SamochowiecJJlld:pubmed
pubmed-article:9884158pubmed:authorpubmed-author:WendelBBlld:pubmed
pubmed-article:9884158pubmed:authorpubmed-author:GscheidelNNlld:pubmed
pubmed-article:9884158pubmed:issnTypePrintlld:pubmed
pubmed-article:9884158pubmed:volume22lld:pubmed
pubmed-article:9884158pubmed:ownerNLMlld:pubmed
pubmed-article:9884158pubmed:authorsCompleteYlld:pubmed
pubmed-article:9884158pubmed:pagination2108-10lld:pubmed
pubmed-article:9884158pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:meshHeadingpubmed-meshheading:9884158-...lld:pubmed
pubmed-article:9884158pubmed:year1998lld:pubmed
pubmed-article:9884158pubmed:articleTitleHuman mu-opioid receptor variation and alcohol dependence.lld:pubmed
pubmed-article:9884158pubmed:affiliationDepartment of Psychiatry, University Hospital Benjamin Franklin, Free University of Berlin, Germany.lld:pubmed
pubmed-article:9884158pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9884158pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9884158lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9884158lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9884158lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9884158lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9884158lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9884158lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9884158lld:pubmed